Insider Stock Trading History of Schleifer Leonard S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schleifer Leonard S since year 2005. The trader's CIK number is 1218629. At the time of this reporting, Schleifer Leonard S is the President & CEO of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Schleifer Leonard S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-12-13 REGN Regeneron Pharmaceuticals Inc Option Ex 250,000 21.92 5,480,000
2016-12-15 REGN Regeneron Pharmaceuticals Inc Option Ex 250,000 20.32 5,080,000
2015-09-02 REGN Regeneron Pharmaceuticals Inc Option Ex 7,226 402.69 2,909,837
2015-01-02 REGN Regeneron Pharmaceuticals Inc Sale 1,500 411.75 617,625
2014-11-12 REGN Regeneron Pharmaceuticals Inc Sale 42,324 400.67 16,957,957
2014-11-11 REGN Regeneron Pharmaceuticals Inc Sale 3,493 400.00 1,397,200
2014-10-31 REGN Regeneron Pharmaceuticals Inc Sale 3,453 400.11 1,381,579
2014-10-27 REGN Regeneron Pharmaceuticals Inc Option Ex 256,808 158.01 40,578,232
2014-10-28 REGN Regeneron Pharmaceuticals Inc Sale 69,112 405.45 28,021,598
2013-10-02 REGN Regeneron Pharmaceuticals Inc Sale 9,162 314.84 2,884,582
2013-10-01 REGN Regeneron Pharmaceuticals Inc Option Ex 29,276 111.01 3,249,928
2013-09-18 REGN Regeneron Pharmaceuticals Inc Option Ex 218,389 9.49 2,072,511
2013-09-19 REGN Regeneron Pharmaceuticals Inc Sale 102,949 305.45 31,446,286
2013-09-09 REGN Regeneron Pharmaceuticals Inc Sale 5,000 276.21 1,381,050
2013-05-01 REGN Regeneron Pharmaceuticals Inc Sale 100,000 238.72 23,872,300
2013-03-19 REGN Regeneron Pharmaceuticals Inc Sale 3,655 175.02 639,698
2013-03-13 REGN Regeneron Pharmaceuticals Inc Sale 4,662 175.01 815,896
2013-03-06 REGN Regeneron Pharmaceuticals Inc Sale 69,003 175.69 12,123,137
2013-03-07 REGN Regeneron Pharmaceuticals Inc Sale 3,534 175.13 618,909
2013-03-05 REGN Regeneron Pharmaceuticals Inc Sale 19,146 175.21 3,354,570
2012-11-16 REGN Regeneron Pharmaceuticals Inc Option Ex 43,757 111.01 4,857,464
2012-05-01 REGN Regeneron Pharmaceuticals Inc Sale 100,000 135.07 13,506,800
2012-02-14 REGN Regeneron Pharmaceuticals Inc Option Ex 500,000 15.14 7,571,500
2011-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 250,000 28.01 7,002,500
2011-09-06 REGN Regeneron Pharmaceuticals Inc Sale 7,900 66.10 522,213
2009-12-15 REGN Regeneron Pharmaceuticals Inc Option Ex 150,000 8.77 1,315,500
2009-10-27 REGN Regeneron Pharmaceuticals Inc Option Ex 31,611 10.44 330,018
2008-09-29 REGN Regeneron Pharmaceuticals Inc Option Ex 73,010 7.41 541,004
2007-12-20 REGN Regeneron Pharmaceuticals Inc Option Ex 37,370 8.62 322,316
2006-11-07 REGN Regeneron Pharmaceuticals Inc Sale 53,986 23.11 1,247,886
2006-11-06 REGN Regeneron Pharmaceuticals Inc Option Ex 150,000 9.06 1,359,300
2006-10-17 REGN Regeneron Pharmaceuticals Inc Sale 30,000 18.02 540,750
2006-09-13 REGN Regeneron Pharmaceuticals Inc Sale 14,100 16.55 233,369
2009-09-13 REGN Regeneron Pharmaceuticals Inc Sale 15,900 16.55 263,176
2006-03-06 REGN Regeneron Pharmaceuticals Inc Sale 700 18.00 12,600
2006-03-07 REGN Regeneron Pharmaceuticals Inc Sale 401 18.00 7,218
2006-03-06 REGN Regeneron Pharmaceuticals Inc Sale 700 18.00 12,600
2006-03-07 REGN Regeneron Pharmaceuticals Inc Sale 401 18.00 7,218
2005-12-27 REGN Regeneron Pharmaceuticals Inc Option Ex 80,000 12.75 1,020,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schleifer Leonard S (President & CEO of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.